Celldex Therapeutics
CLDX
#5014
Rank
NZ$2.30 B
Marketcap
$34.66
Share price
0.80%
Change (1 day)
-48.53%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.93

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.15. In 2022 the company made an earnings per share (EPS) of -$4.13 a decrease over its 2021 EPS that were of -$2.83.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.93-4.75%
2022-$4.1345.73%
2021-$2.83-23.36%
2020-$3.70-41.05%
2019-$6.27-76.95%
2018-$27.2245.03%
2017-$18.77-42.54%
2016-$32.67-3.82%
2015-$33.96-0.76%
2014-$34.2229.41%
2013-$26.450%
2012-$26.45-9.73%
2011-$29.301312.5%
2010-$2.07-95.79%
2009-$49.22-49.64%
2008-$97.75-82.64%
2007-$563.14-44.98%
2006-$1,0241270.83%
2005-$74.6733.33%
2004-$56.00-10%
2003-$62.23-16.67%
2002-$74.67-38.46%
2001-$121.34-4.88%
2000-$127.56-81.66%
1999-$695.37-87.2%
1998-$5,430206.39%
1997-$1,77213.02%
1996-$1,568

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.93 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.47-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$20.88 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.46-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.22-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.05-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.99-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA